Visakhapatnam, India

Svb Janardhan Garikipati


Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Svb Janardhan Garikipati: Innovator in Pharmaceutical Formulations

Introduction

Svb Janardhan Garikipati is a notable inventor based in Visakhapatnam, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment. With a total of three patents to his name, Garikipati's work is recognized for its potential impact on patient care.

Latest Patents

Garikipati's latest patents focus on stable liquid formulations of cyclophosphamide. These formulations comprise cyclophosphamide and at least one pharmaceutically acceptable excipient, with a moisture content of less than about 2.0% by weight. The invention outlines a process for reducing moisture content from cyclophosphamide or its liquid compositions. Furthermore, it details methods for using these stable formulations for parenteral administration, either as ready-to-use or ready-to-dilute options for treating various cancer disorders.

Career Highlights

Throughout his career, Garikipati has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Dr. Reddy's Laboratories and Avyxa Holdings. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovation.

Collaborations

Garikipati has collaborated with several professionals in his field, including Riyaz Ahmed Shaik and Ananya Saha. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Svb Janardhan Garikipati is a distinguished inventor whose work in stable liquid formulations of cyclophosphamide has the potential to improve cancer treatment options. His contributions to the pharmaceutical industry reflect a commitment to innovation and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…